Sign inJoin waitlistJoin the waitlist

Arvind Dasari

Professor, GI Medical Oncology · University of Texas M D Anderson Cancer Center

Credentials: · · · · ·

History

University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present

University of Colorado School of Medicine
2008–2011
UPMC
2005–2008
Doctor of Medicine
1998–2002

Research

Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
JAMA Oncology · 2017 · First of 8 authors · 2,789 citations
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer
Journal of Clinical Oncology · 2015 · 567 citations
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018
JAMA Oncology · 2019 · 485 citations

Scott Kopetz
53 papers
Michael Overman
47 papers
Kanwal Raghav
41 papers
Van Morris
41 papers · 3 as a fellow
James Yao
37 papers
Daniel Halperin
33 papers · 4 as a fellow
Bryan Kee
31 papers
Cathy Eng
30 papers
Christine Parseghian
27 papers · 4 as a fellow
Robert Wolff
24 papers
BJ
Benny Johnson
19 papers
Jason Willis
16 papers · 1 as a fellow

Clinical trials

A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2025–2028
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
Principal investigator · Recruiting
M.D. Anderson Cancer Center
2019–2028
Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2019–2028
Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer
Principal investigator · Terminated · Phase 1
National Cancer Institute (NCI)
2019–2022